Co-Authors
This is a "connection" page, showing publications co-authored by Giovanni Di Perri and Andrea Calcagno.
Connection Strength
4.563
-
Risk for SARS-CoV-2 Infection in Healthcare Workers, Turin, Italy. Emerg Infect Dis. 2021 Jan; 27(1).
Score: 0.907
-
Co-infection with other respiratory pathogens in COVID-19 patients. Clin Microbiol Infect. 2021 Feb; 27(2):297-298.
Score: 0.898
-
Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases. Lancet Infect Dis. 2021 07; 21(7):914-915.
Score: 0.235
-
On the SARS-CoV-2 "Variolation Hypothesis": No Association Between Viral Load of Index Cases and COVID-19 Severity of Secondary Cases. Front Microbiol. 2021; 12:646679.
Score: 0.234
-
Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients. Viruses. 2021 02 11; 13(2).
Score: 0.232
-
Cerebrospinal fluid biomarkers in patients with central nervous system infections: a retrospective study. CNS Spectr. 2020 06; 25(3):402-408.
Score: 0.206
-
The Influence of Pharmacogenetic Variants in HIV/Tuberculosis Coinfected Patients in Uganda in the SOUTH Study. Clin Pharmacol Ther. 2019 08; 106(2):450-457.
Score: 0.204
-
The clinical pharmacology of integrase inhibitors. Expert Rev Clin Pharmacol. 2019 Jan; 12(1):31-44.
Score: 0.200
-
Effect of ABCC2 and ABCG2 Gene Polymorphisms and CSF-to-Serum Albumin Ratio on Ceftriaxone Plasma and Cerebrospinal Fluid Concentrations. J Clin Pharmacol. 2018 12; 58(12):1550-1556.
Score: 0.193
-
Antiviral activity of maraviroc plus mirtazapine in a low-risk HIV-negative patient with progressive multifocal leukoencephalopathy. Infez Med. 2018 Jun 01; 26(2):160-163.
Score: 0.193
-
Lower dolutegravir plasma concentrations in HIV-positive patients receiving valproic acid. J Antimicrob Chemother. 2018 03 01; 73(3):826-827.
Score: 0.189
-
Cerebrospinal fluid viral load and neopterin in HIV-positive patients with undetectable viraemia. Antivir Ther. 2017; 22(6):539-543.
Score: 0.176
-
High Incidence of Infections in HIV-positive Patients Treated for Lymphoproliferative Disorders. Curr HIV Res. 2017; 15(4):258-265.
Score: 0.175
-
Seroprevalence of SARS-CoV-2 Among Workers in Northern Italy. Ann Work Expo Health. 2022 02 18; 66(2):224-232.
Score: 0.062
-
Analytical Validation and Clinical Application of Rapid Serological Tests for SARS-CoV-2 Suitable for Large-Scale Screening. Diagnostics (Basel). 2021 May 12; 11(5).
Score: 0.059
-
Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection. Thromb Res. 2020 12; 196:432-434.
Score: 0.057
-
Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. Clin Exp Rheumatol. 2020 May-Jun; 38(3):529-532.
Score: 0.055
-
Early low-molecular-weight heparin administration is associated with shorter time to SARS-CoV-2 swab negativity. Antivir Ther. 2020; 25(6):327-333.
Score: 0.054
-
Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate are not transported by Concentrative Nucleoside Transporter 2. Diagn Microbiol Infect Dis. 2019 Jun; 94(2):202-204.
Score: 0.048
-
Pharmacokinetic Changes during Pregnancy According to Genetic Variants: a Prospective Study in HIV-Infected Patients Receiving Atazanavir-Ritonavir. Antimicrob Agents Chemother. 2018 07; 62(7).
Score: 0.048
-
The outcome of HIV-positive late presenters according to detectable CMV DNA and anti-CMV treatment. Antivir Ther. 2018; 23(5):451-456.
Score: 0.047
-
Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients. J Antimicrob Chemother. 2017 Nov 01; 72(11):3163-3166.
Score: 0.046
-
Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokinetics. Pharmacogenomics. 2017 Jun; 18(9):865-880.
Score: 0.045